BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 2020;16:303-18. [PMID: 32332985 DOI: 10.1038/s41582-020-0344-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 96] [Article Influence: 28.5] [Reference Citation Analysis]
Number Citing Articles
1 Araújo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG. Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities. Cells 2022;11:2908. [PMID: 36139483 DOI: 10.3390/cells11182908] [Reference Citation Analysis]
2 Pan Y, Cai W, Huang J, Cheng A, Wang M, Yin Z, Jia R. Pyroptosis in development, inflammation and disease. Front Immunol 2022;13:991044. [DOI: 10.3389/fimmu.2022.991044] [Reference Citation Analysis]
3 Xing N, Dong Z, Wu Q, Kan P, Han Y, Cheng X, Zhang B. Identification and validation of key molecules associated with humoral immune modulation in Parkinson’s disease based on bioinformatics. Front Immunol 2022;13:948615. [DOI: 10.3389/fimmu.2022.948615] [Reference Citation Analysis]
4 Luo J, Wu H, Li J, Xian W, Li W, Locascio JJ, Pei Z, Liu G. Joint Modeling Study Identifies Blood-Based Transcripts Link to Cognitive Decline in Parkinson's Disease. Mov Disord 2022. [PMID: 36087011 DOI: 10.1002/mds.29213] [Reference Citation Analysis]
5 Cunha DMG, Becegato M, Meurer YSR, Lima AC, Gonçalves N, Bioni VS, Engi SA, Bianchi PC, Cruz FC, Santos JR, Silva RH. Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats. Front Neurosci 2022;16:923957. [DOI: 10.3389/fnins.2022.923957] [Reference Citation Analysis]
6 Hurben AK, Tretyakova NY. Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson's Disease: Evidence, Tools, and Outlook. Chem Res Toxicol 2022. [PMID: 35994383 DOI: 10.1021/acs.chemrestox.2c00193] [Reference Citation Analysis]
7 Karpiel I, Starcevic A, Urzeniczok M. Database and AI Diagnostic Tools Improve Understanding of Lung Damage, Correlation of Pulmonary Disease and Brain Damage in COVID-19. Sensors (Basel) 2022;22:6312. [PMID: 36016071 DOI: 10.3390/s22166312] [Reference Citation Analysis]
8 Levin LA, Patrick C, Choudry NB, Sharif NA, Goldberg JL. Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future. Front Neurol 2022;13:964197. [DOI: 10.3389/fneur.2022.964197] [Reference Citation Analysis]
9 Gonzalez De La Cruz E, Vo Q, Moon K, McFarland KN, Weinrich M, Williams T, Giasson BI, Chakrabarty P. MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice. Int J Mol Sci 2022;23:8175. [PMID: 35897751 DOI: 10.3390/ijms23158175] [Reference Citation Analysis]
10 Chen L, Wang Y, Huang J, Hu B, Huang W. Identification of Immune-Related Hub Genes in Parkinson’s Disease. Front Genet 2022;13:914645. [DOI: 10.3389/fgene.2022.914645] [Reference Citation Analysis]
11 Olivo S, Furlanis G, Buoite Stella A, Fabris M, Milanic R, Zanusso G, Manganotti P. Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome. Acta Neurol Belg. [DOI: 10.1007/s13760-022-02023-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Domenighetti C, Douillard V, Sugier P, Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov‐blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Gourraud P, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol J, Chartier‐harlin M, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Duga S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BP, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Correia Guedes L, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez‐fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Ygland Rödström E, Clarke CE, Morrison KE, Tan M, Kraincmd D, Burbulla LF, Farrer MJ, Krüger R, Gasser T, Sharma M, Vince N, Elbaz A; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage‐PD) Consortium. The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease Revisited. Movement Disorders. [DOI: 10.1002/mds.29133] [Reference Citation Analysis]
13 Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front Aging Neurosci 2022;14:879021. [PMID: 35754962 DOI: 10.3389/fnagi.2022.879021] [Reference Citation Analysis]
14 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
15 Xu J, Zhao C, Liu Y, Xu C, Qin B, Liang H. Genetic correlation between thyroid hormones and Parkinson's disease. Clin Exp Immunol 2022;208:372-9. [PMID: 35511827 DOI: 10.1093/cei/uxac044] [Reference Citation Analysis]
16 Sittipo P, Choi J, Lee S, Lee YK. The function of gut microbiota in immune-related neurological disorders: a review. J Neuroinflammation 2022;19:154. [PMID: 35706008 DOI: 10.1186/s12974-022-02510-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gopinath A, Mackie P, Hashimi B, Buchanan AM, Smith AR, Bouchard R, Shaw G, Badov M, Saadatpour L, Gittis A, Ramirez-Zamora A, Okun MS, Streit WJ, Hashemi P, Khoshbouei H. DAT and TH expression marks human Parkinson's disease in peripheral immune cells. NPJ Parkinsons Dis 2022;8:72. [PMID: 35672374 DOI: 10.1038/s41531-022-00333-8] [Reference Citation Analysis]
18 Annesley SJ, Allan CY, Sanislav O, Evans A, Fisher PR. Dysregulated Gene Expression in Lymphoblasts from Parkinson’s Disease. Proteomes 2022;10:20. [DOI: 10.3390/proteomes10020020] [Reference Citation Analysis]
19 Polinski NK, Martinez TN, Ramboz S, Sasner M, Herberth M, Switzer R, Ahmad SO, Pelligrino LJ, Clark SW, Marcus JN, Smith SM, Dave KD, Frasier MA. The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models. Dis Model Mech 2022;15:dmm049192. [PMID: 35419585 DOI: 10.1242/dmm.049192] [Reference Citation Analysis]
20 Vidović M, Rikalovic MG. Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches. Cells 2022;11:1732. [PMID: 35681426 DOI: 10.3390/cells11111732] [Reference Citation Analysis]
21 Zhang L, Zhang Y, Fan D. Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review. Front Aging Neurosci 2022;14:890816. [DOI: 10.3389/fnagi.2022.890816] [Reference Citation Analysis]
22 Zhang M, Li C, Ren J, Wang H, Yi F, Wu J, Tang Y. The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson’s Disease. Front Aging Neurosci 2022;14:909303. [DOI: 10.3389/fnagi.2022.909303] [Reference Citation Analysis]
23 Naito T, Satake W, Cha PC, Kobayashi K, Murata M, Toda T. Comparative whole transcriptome analysis of Parkinson's disease focusing on the efficacy of zonisamide. J Neurol Neurosurg Psychiatry 2022;93:509-12. [PMID: 35264450 DOI: 10.1136/jnnp-2021-328742] [Reference Citation Analysis]
24 Li G, Cao Y, Tang X, Huang J, Cai L, Zhou L. The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders. J Cereb Blood Flow Metab 2022;:271678X221098145. [PMID: 35484910 DOI: 10.1177/0271678X221098145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lee EJ, Choi Y, Lee HJ, Hwang DW, Lee DS. Human neural stem cell-derived extracellular vesicles protect against Parkinson's disease pathologies. J Nanobiotechnology 2022;20:198. [PMID: 35468855 DOI: 10.1186/s12951-022-01356-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gschmack E, Monoranu CM, Marouf H, Meyer S, Lessel L, Idris R, Berg D, Maetzler W, Steigerwald F, Volkmann J, Gerlach M, Riederer P, Koutsilieri E, Scheller C. Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's disease. J Neural Transm (Vienna) 2022. [PMID: 35364741 DOI: 10.1007/s00702-022-02495-4] [Reference Citation Analysis]
27 Mamais A, Kaganovich A, Harvey K. Convergence of signalling pathways in innate immune responses and genetic formof Parkinson’s disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105721] [Reference Citation Analysis]
28 Russo I, Bubacco L, Greggio E. LRRK2 as a target for modulating immune system responses. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105724] [Reference Citation Analysis]
29 Koo J, Kim G, Nam K, Choi J. Unleashing cell-penetrating peptide applications for immunotherapy. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.03.010] [Reference Citation Analysis]
30 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
31 Wang P, Luo M, Zhou W, Jin X, Xu Z, Yan S, Li Y, Xu C, Cheng R, Huang Y, Lin X, Yao L, Nie H, Jiang Q. Global Characterization of Peripheral B Cells in Parkinson's Disease by Single-Cell RNA and BCR Sequencing. Front Immunol 2022;13:814239. [PMID: 35250991 DOI: 10.3389/fimmu.2022.814239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
32 Li R, Tropea TF, Baratta LR, Zuroff L, Diaz-Ortiz ME, Zhang B, Shinoda K, Rezk A, Alcalay RN, Chen-Plotkin A, Bar-Or A. Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study. Neurol Neuroimmunol Neuroinflamm 2022;9:e1125. [PMID: 34955458 DOI: 10.1212/NXI.0000000000001125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Vijayakumar D, Jankovic J. Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies. CNS Drugs 2022. [PMID: 35212935 DOI: 10.1007/s40263-022-00903-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu Z, Chan RB, Cai Z, Liu X, Wu Y, Yu Z, Feng T, Yang Y, Zhang J. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease. J Neuroinflammation 2022;19:53. [PMID: 35193594 DOI: 10.1186/s12974-022-02413-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Hulse J, Bhaskar K. Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease. Front Mol Neurosci 2022;15:805169. [DOI: 10.3389/fnmol.2022.805169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kasen A, Houck C, Burmeister AR, Sha Q, Brundin L, Brundin P. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105654] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Lai TT, Kim YJ, Ma H, Kim YE. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy. JMD 2022;15:1-14. [DOI: 10.14802/jmd.21078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Garcia P, Jürgens‐wemheuer W, Uriarte Huarte O, Michelucci A, Masuch A, Brioschi S, Weihofen A, Koncina E, Coowar D, Heurtaux T, Glaab E, Balling R, Sousa C, Kaoma T, Nicot N, Pfander T, Schulz‐schaeffer W, Allouche A, Fischer N, Biber K, Kleine‐borgmann F, Mittelbronn M, Ostaszewski M, Schmit KJ, Buttini M. Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease. Glia. [DOI: 10.1002/glia.24149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
39 Lee SB, Kim YJ, Hwang S, Son H, Lee SK, Park KI, Kim YG. Predicting Parkinson's disease using gradient boosting decision tree models with electroencephalography signals. Parkinsonism Relat Disord 2022;95:77-85. [PMID: 35051896 DOI: 10.1016/j.parkreldis.2022.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
40 Liu J, Zhang Y, Ye T, Yu Q, Yu J, Yuan S, Gao X, Wan X, Zhang R, Han W, Zhang Y. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota. J Agric Food Chem 2022;70:184-95. [PMID: 35016506 DOI: 10.1021/acs.jafc.1c06998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Navarro E, Udine E, de Paiva Lopes K, Parks M, Riboldi G, Schilder BM, Humphrey J, Snijders GJL, Vialle RA, Zhuang M, Sikder T, Argyrou C, Allan A, Chao MJ, Farrell K, Henderson B, Simon S, Raymond D, Elango S, Ortega RA, Shanker V, Swan M, Zhu CW, Ramdhani R, Walker RH, Tse W, Sano M, Pereira AC, Ahfeldt T, Goate AM, Bressman S, Crary JF, de Witte L, Frucht S, Saunders-Pullman R, Raj T. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells. Nat Aging 2021;1:850-63. [PMID: 35005630 DOI: 10.1038/s43587-021-00110-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tian J, Dai SB, Jiang SS, Yang WY, Yan YQ, Lin ZH, Dong JX, Liu Y, Zheng R, Chen Y, Zhang BR, Pu JL. Specific immune status in Parkinson's disease at different ages of onset. NPJ Parkinsons Dis 2022;8:5. [PMID: 35013369 DOI: 10.1038/s41531-021-00271-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Huang L, Han Y, Zhou Q, Sun Z, Yan J. Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson's disease by promoting Nrf2/NQO-1 pathway. Transl Neurosci 2022;13:301-8. [PMID: 36160039 DOI: 10.1515/tnsci-2022-0239] [Reference Citation Analysis]
44 Fleming SM, Davis A, Simons E. Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies. Neuropharmacology 2022;202:108870. [PMID: 34742741 DOI: 10.1016/j.neuropharm.2021.108870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
45 Miao Q, Chai Z, Song L, Wang Q, Song G, Wang J, Yu J, Xiao B, Ma C. The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson's disease mice. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Blesa J, Foffani G, Dehay B, Bezard E, Obeso JA. Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nat Rev Neurosci 2021. [PMID: 34907352 DOI: 10.1038/s41583-021-00542-9] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
47 Lama J, Buhidma Y, Fletcher E, Duty S. Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research. Neuronal Signaling 2021;5:NS20210026. [DOI: 10.1042/ns20210026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Chen J, Chen Y, Du X, Liu G, Fei X, Peng JR, Zhang X, Xiao F, Wang X, Yang X, Feng Z. Integrative Studies of Human Cord Blood Derived Mononuclear Cells and Umbilical Cord Derived Mesenchyme Stem Cells in Ameliorating Bronchopulmonary Dysplasia. Front Cell Dev Biol 2021;9:679866. [PMID: 34858969 DOI: 10.3389/fcell.2021.679866] [Reference Citation Analysis]
49 Gorecki AM, Anyaegbu CC, Anderton RS. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 2021;10:47. [PMID: 34814947 DOI: 10.1186/s40035-021-00271-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Golli T, Kastrin A, Pokorn M, Rener-Primec Z. Immunosuppression and immunization: Vaccination in pediatric patients with neuromuscular diseases treated with steroids or immune-modulating drugs. Eur J Paediatr Neurol 2021;35:158-64. [PMID: 34752936 DOI: 10.1016/j.ejpn.2021.10.009] [Reference Citation Analysis]
51 Tsukita K, Sakamaki-Tsukita H, Takahashi R. Lower Circulating Lymphocyte Count Predicts ApoE ε4-Related Cognitive Decline in Parkinson's Disease. Mov Disord 2021. [PMID: 34647353 DOI: 10.1002/mds.28799] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biol 2021;47:102134. [PMID: 34600334 DOI: 10.1016/j.redox.2021.102134] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
53 Bologna M, Truong D, Jankovic J. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J Neurol Sci 2021;:120012. [PMID: 34642022 DOI: 10.1016/j.jns.2021.120012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Paul KC, Binder AM, Horvath S, Kusters C, Yan Q, Rosario ID, Yu Y, Bronstein J, Ritz B. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease. BMC Genomics 2021;22:696. [PMID: 34565328 DOI: 10.1186/s12864-021-08009-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 McDonagh Hull P, Lashewicz BM, Fritzler MJ. High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection. Med Hypotheses 2021;155:110677. [PMID: 34560443 DOI: 10.1016/j.mehy.2021.110677] [Reference Citation Analysis]
56 Liao H, Winkler J, Wißfeld J, Shahraz A, Klaus C, Neumann H. Low molecular weight polysialic acid prevents lipopolysaccharide-induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice. Glia 2021;69:2845-62. [PMID: 34406679 DOI: 10.1002/glia.24073] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
57 Wang P, Yao L, Luo M, Zhou W, Jin X, Xu Z, Yan S, Li Y, Xu C, Cheng R, Huang Y, Lin X, Ma K, Cao H, Liu H, Xue G, Han F, Nie H, Jiang Q. Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease. Cell Discov 2021;7:52. [PMID: 34282123 DOI: 10.1038/s41421-021-00280-3] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
58 Li Y, Huang H, Liu B, Zhang Y, Pan X, Yu XY, Shen Z, Song YH. Inflammasomes as therapeutic targets in human diseases. Signal Transduct Target Ther 2021;6:247. [PMID: 34210954 DOI: 10.1038/s41392-021-00650-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
59 Dong L, Zheng YM, Luo XG, He ZY. High Inflammatory Tendency Induced by Malignant Stimulation Through Imbalance of CD28 and CTLA-4/PD-1 Contributes to Dopamine Neuron Injury. J Inflamm Res 2021;14:2471-82. [PMID: 34140795 DOI: 10.2147/JIR.S316439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Polinski NK, Martinez TN, Gorodinsky A, Gareus R, Sasner M, Herberth M, Switzer R, Ahmad SO, Cosden M, Kandebo M, Drolet RE, Buckett PD, Shan W, Chen Y, Pellegrino LJ, Ellsworth GD, Dungan LB, Hirst WD, Clark SW, Dave KD. Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model. PLoS One 2021;16:e0252325. [PMID: 34106956 DOI: 10.1371/journal.pone.0252325] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
61 Muñoz-Delgado L, Macías-García D, Jesús S, Martín-Rodríguez JF, Labrador-Espinosa MÁ, Jiménez-Jaraba MV, Adarmes-Gómez A, Carrillo F, Mir P. Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Parkinson's Disease. Mov Disord 2021. [PMID: 34101890 DOI: 10.1002/mds.28685] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
62 Błaszczyk N, Rosiak A, Kałużna-czaplińska J. The Potential Role of Cinnamon in Human Health. Forests 2021;12:648. [DOI: 10.3390/f12050648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
63 Over L, Brüggemann N, Lohmann K. Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review. J Neuromuscul Dis 2021;8:341-56. [PMID: 33459660 DOI: 10.3233/JND-200598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Burtscher J, Millet GP. Hypoxia, Acidification and Inflammation: Partners in Crime in Parkinson’s Disease Pathogenesis? Immuno 2021;1:78-90. [DOI: 10.3390/immuno1020006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Naito T, Satake W, Ogawa K, Suzuki K, Hirata J, Foo JN, Tan EK, Toda T, Okada Y. Trans-Ethnic Fine-Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease. Mov Disord 2021;36:1805-14. [PMID: 33973677 DOI: 10.1002/mds.28583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Klinger D, Hill BL, Barda N, Halperin E, Gofrit ON, Greenblatt CL, Rappoport N, Linial M, Bercovier H. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease. Vaccines (Basel) 2021;9:491. [PMID: 34064775 DOI: 10.3390/vaccines9050491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
67 Rasmussen MK, Mestre H, Nedergaard M. Fluid Transport in the Brain. Physiol Rev 2021. [PMID: 33949874 DOI: 10.1152/physrev.00031.2020] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 48.0] [Reference Citation Analysis]
68 Menculini G, Chipi E, Paolini Paoletti F, Gaetani L, Nigro P, Simoni S, Mancini A, Tambasco N, Di Filippo M, Tortorella A, Parnetti L. Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis. Int J Mol Sci 2021;22:4440. [PMID: 33922780 DOI: 10.3390/ijms22094440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
69 Mancini A, Ghiglieri V, Parnetti L, Calabresi P, Di Filippo M. Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction. Front Immunol 2021;12:644294. [PMID: 33953715 DOI: 10.3389/fimmu.2021.644294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
70 George S, Tyson T, Rey NL, Sheridan R, Peelaerts W, Becker K, Schulz E, Meyerdirk L, Burmeister AR, von Linstow CU, Steiner JA, Galvis MLE, Ma J, Pospisilik JA, Labrie V, Brundin L, Brundin P. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils. J Parkinsons Dis 2021;11:585-603. [PMID: 33579871 DOI: 10.3233/JPD-202351] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Duwa R, Jeong J, Yook S. Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease. J Pharm Investig 2021;51:465-81. [DOI: 10.1007/s40005-021-00521-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
72 Navarro E, Norden DM, Trojanowski PJ, Godbout JP, López MG. Central Activation of Alpha7 Nicotinic Signaling Attenuates LPS-Induced Neuroinflammation and Sickness Behavior in Adult but Not in Aged Animals. Molecules 2021;26:2107. [PMID: 33916910 DOI: 10.3390/molecules26082107] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
73 Cockey SG, McFarland KN, Koller EJ, Brooks MMT, Gonzalez De La Cruz E, Cruz PE, Ceballos-Diaz C, Rosario AM, Levites YR, Borchelt DR, Golde TE, Giasson BI, Chakrabarty P. Il-10 signaling reduces survival in mouse models of synucleinopathy. NPJ Parkinsons Dis 2021;7:30. [PMID: 33741985 DOI: 10.1038/s41531-021-00169-8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
74 Ong LK, Briggs GD, Guan L, Dunkley PR, Dickson PW. Peripheral inflammation induces long-term changes in tyrosine hydroxylase activation in the substantia nigra. Neurochem Int 2021;146:105022. [PMID: 33746005 DOI: 10.1016/j.neuint.2021.105022] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Nam Y, Moon GJ, Kim SR. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases. Int J Mol Sci 2021;22:3064. [PMID: 33802760 DOI: 10.3390/ijms22063064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Thomas GEC, Zarkali A, Ryten M, Shmueli K, Gil-Martinez AL, Leyland LA, McColgan P, Acosta-Cabronero J, Lees AJ, Weil RS. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease. Brain 2021;144:1787-98. [PMID: 33704443 DOI: 10.1093/brain/awab084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH, Peckham D, McDermott MF. Neurodegenerative Disease and the NLRP3 Inflammasome. Front Pharmacol 2021;12:643254. [PMID: 33776778 DOI: 10.3389/fphar.2021.643254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
78 Andersen MS, Bandres-Ciga S, Reynolds RH, Hardy J, Ryten M, Krohn L, Gan-Or Z, Holtman IR, Pihlstrøm L; International Parkinson's Disease Genomics Consortium. Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis. Ann Neurol 2021;89:942-51. [PMID: 33502028 DOI: 10.1002/ana.26032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
79 Jensen MP, Jacobs BM, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce AJ; International Parkinson's Disease Genomics Consortium (IPDGC). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. Ann Neurol 2021;89:803-12. [PMID: 33527442 DOI: 10.1002/ana.26034] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
80 Gonçalves VC, Cuenca-Bermejo L, Fernandez-Villalba E, Martin-Balbuena S, da Silva Fernandes MJ, Scorza CA, Herrero MT. Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson's Disease. Neuroscientist 2021;:1073858421990000. [PMID: 33583239 DOI: 10.1177/1073858421990000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Ma T, Wang F, Xu S, Huang JH. Meningeal immunity: Structure, function and a potential therapeutic target of neurodegenerative diseases. Brain Behav Immun 2021;93:264-76. [PMID: 33548498 DOI: 10.1016/j.bbi.2021.01.028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 18.0] [Reference Citation Analysis]
83 Huang S, Yuan H, Li W, Liu X, Zhang X, Xiang D, Luo S. Polygonatum sibiricum Polysaccharides Protect against MPP-Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways. Oxid Med Cell Longev 2021;2021:8843899. [PMID: 33520086 DOI: 10.1155/2021/8843899] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
84 de Araújo FM, Cuenca-Bermejo L, Fernández-Villalba E, Costa SL, Silva VDA, Herrero MT. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy. Cell Mol Neurobiol 2021. [PMID: 33387119 DOI: 10.1007/s10571-020-01027-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
85 Bhuiyan P, Wang YW, Sha HH, Dong HQ, Qian YN. Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases. Neural Regen Res 2021;16:2184-97. [PMID: 33818491 DOI: 10.4103/1673-5374.310608] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
86 Forloni G, La Vitola P, Cerovic M, Balducci C. Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight. Prog Mol Biol Transl Sci 2021;177:175-202. [PMID: 33453941 DOI: 10.1016/bs.pmbts.2020.11.001] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
87 Tan JSY, Chao YX, Rötzschke O, Tan EK. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease. Int J Mol Sci 2020;21:E9302. [PMID: 33291304 DOI: 10.3390/ijms21239302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
88 Tarakad A, Jankovic J. Recent advances in understanding and treatment of Parkinson's disease. Fac Rev 2020;9:6. [PMID: 33659938 DOI: 10.12703/b/9-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bonam SR, Muller S. Parkinson's disease is an autoimmune disease: A reappraisal. Autoimmun Rev 2020;19:102684. [PMID: 33131704 DOI: 10.1016/j.autrev.2020.102684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
90 Mignot E, Black S. Narcolepsy risk and COVID-19. J Clin Sleep Med 2020;16:1831-3. [PMID: 32621581 DOI: 10.5664/jcsm.8668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Chua LL, Ho P, Toh J, Tan EK. Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila. Aging (Albany NY) 2020;12:18561-70. [PMID: 32990658 DOI: 10.18632/aging.103843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Meenambal R, Srinivas Bharath MM. Nanocarriers for effective nutraceutical delivery to the brain. Neurochem Int 2020;140:104851. [PMID: 32976906 DOI: 10.1016/j.neuint.2020.104851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
93 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
94 Do HTT, Cho J. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles. Int J Mol Sci 2020;21:E6211. [PMID: 32867357 DOI: 10.3390/ijms21176211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
95 Illes P. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases. Int J Mol Sci 2020;21:E5996. [PMID: 32825423 DOI: 10.3390/ijms21175996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
96 Young MJ, O'Hare M, Matiello M, Schmahmann JD. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun 2020;89:601-3. [PMID: 32681865 DOI: 10.1016/j.bbi.2020.07.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
97 Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 2020;91:795-808. [PMID: 32576618 DOI: 10.1136/jnnp-2019-322338] [Cited by in Crossref: 136] [Cited by in F6Publishing: 116] [Article Influence: 68.0] [Reference Citation Analysis]
98 Ostendorf F, Metzdorf J, Gold R, Haghikia A, Tönges L. Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease. Molecules 2020;25:E2502. [PMID: 32481507 DOI: 10.3390/molecules25112502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]